← 返回

BV6 诱导的儿童横纹肌肉瘤球状体对 NK 细胞杀伤敏感性的表征

英文原题:Characterization of BV6-Induced Sensitization to the NK Cell Killing of Pediatric Rhabdomyosarcoma Spheroids.

查看英文原题

Characterization of BV6-Induced Sensitization to the NK Cell Killing of Pediatric Rhabdomyosarcoma Spheroids.

PubMed 2023/03/15(内容时间) Cells Q2 · IF 6(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

尽管儿童横纹肌肉瘤(RMS)总体生存率在过去数十年有所提高,侵袭性最强的腺泡型RMS仍迫切需要新的治疗策略。RMS细胞通过提高凋亡抑制蛋白(IAP)表达,逃避细胞死亡和免疫控制;这一特征可利用Smac模拟物靶向。本研究使用Smac模拟物BV6使RMS肿瘤球重新对细胞死亡敏感,并增强自然杀伤(NK)细胞介导的杀伤。单独使用BV6未能抑制肿瘤球生长,但BV6预处理后与NK细胞共培养可显著破坏肿瘤球结构。机制上,BV6迅速降解IAP并激活RMS肿瘤球中的NF-κB信号通路;RNA测序证实NF-κB活化并发现大量受BV6调控的基因。此外,BV6解除IAP对半胱天冬酶的抑制,其中半胱天冬酶8可能发挥重要作用,因为敲低后NK细胞介导的攻击减弱。研究加深了对BV6使RMS肿瘤球对细胞毒性免疫细胞敏感之机制的理解,提示Smac模拟物联合细胞免疫疗法值得进一步开发。

展开英文摘要原文

Although the overall survival in pediatric rhabdomyosarcoma (RMS) has increased over the last decades, the most aggressive subtype of alveolar RMS is in dire need of novel treatment strategies. RMS cells evade cell death induction and immune control by increasing the expression of inhibitors of apoptosis proteins (IAPs), which can be exploited and targeted with stimulation with Smac mimetics.

Here, we used the Smac mimetic BV6 to re-sensitize RMS spheroids to cell death, which increased killing induced by natural killer (NK) cells. Single BV6 treatment of RMS spheroids did not reduce spheroidal growth.

However, we observed significant spheroidal decomposition upon BV6 pre-treatment combined with NK cell co-cultivation. Molecularly, IAPs s are rapidly degraded by BV6, which activates NF- B signal transduction pathways in RMS spheroids. RNA sequencing analysis validated NF- B activation and identified a plethora of BV6-regulated genes.

Additionally, BV6 released caspases from IAP-mediated inhibition.

Here, caspase-8 might play a major role, as knockdown experiments resulted in decreased NK cell-mediated attack. Taken together, we improved the understanding of the BV6 mechanism of RMS spheroid sensitization to cytotoxic immune cells, which could be suitable for the development of novel combinatory cellular immunotherapy with Smac mimetics.

论文信息

作者
Särchen V、Reindl LM、Wiedemann S、Shanmugalingam S、Bukur T、Becker J、Suchan M、Ullrich E
单位
Institute for Experimental Cancer Research in Pediatrics, Goethe-University, 60528 Frankfurt, Germany.Germany
文献类型
非美国政府资助研究
期刊
Cells2023 Mar 15
原文标识
PubMed 36980247 · DOI 10.3390/cells12060906